Craig-Hallum initiated coverage of Eupraxia Pharmaceuticals (EPRX) with a Buy rating and $12 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on EPRX: Eupraxia Pharmaceuticals Announces CFO Succession Amid Strategic Advancements Eupraxia Pharmaceuticals announces CFO succession